EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Challenges and mitigation strategies associated with Burkholderia cepacia complex contamination in pharmaceutical manufacturing

Sethuraman Prem Kumar, Karupanagounder Thangaraj Uthra, Vellapandian Chitra, Narayanasamy Damodharan, Gururaja Perumal Pazhani iD

Archives of Microbiology · 2024-04 · 206 (4)

DOI: 10.1007/s00203-024-03921-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archives of Microbiology, online erschienen am 14.03.2024. Verfasst von Sethuraman Prem Kumar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Quality Assurance, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, 603203,…. Hauptthemen laut MEDLINE: Burkholderia cepacia complex, Burkholderia Infections, Cystic Fibrosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 69 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Burkholderia cepacia complex (BCC) is a Gram-negative, non-spore-forming bacterium with more than 20 opportunistic pathogenic species, most commonly found in soil and water. Due to their rapid mutation rates, these organisms are adaptable and possess high genomic plasticity. BCC can cause life-threatening infections in immunocompromised individuals, such as those with cystic fibrosis, chronic granulomatous disease, and neonates. BCC contamination is a significant concern in pharmaceutical manufacturing, frequently causing non-sterile product recalls. BCC has been found in purified water, cosmetics, household items, and even ultrasound gel used in veterinary practices. Pharmaceuticals, personal care products, and cleaning solutions have been implicated in numerous outbreaks worldwide, highlighting the risks associated with intrinsic manufacturing site contamination. Regulatory compliance, product safety, and human health protection depend on testing for BCC in pharmaceutical manufacturing. Identification challenges exist, with BCC often misidentified as other bacteria like non-lactose fermenting Escherichia coli or Pseudomonas spp., particularly in developing countries where reporting BCC in pharmaceuticals remains limited. This review comprehensively aims to address the organisms causing BCC contamination, genetic diversity, identification challenges, regulatory requirements, and mitigation strategies. Recommendations are proposed to aid pharmaceutical chemists in managing BCC-associated risks and implementing prevention strategies within manufacturing processes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Burkholderia cepacia complexBurkholderia InfectionsCystic FibrosisInfant, NewbornHumansWaterPharmaceutical Preparations

Stichwörter der Autor:innen

Burkholderia cepacia ComplexNon-sterile preparations and pharmaceuticalsQuality control

Substanzen

WaterPharmaceutical Preparations

Autor:innen und Institutionen

  • Department of Pharmaceutical Quality Assurance, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, 603203, India.
  • Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, 603 203, India.
  • Department of Pharmacology, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, 603203, India.
  • Department of Pharmaceutics, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, 603203, India.
  • Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, 603 203, India. pazhanigp@gmail.com.

ORCID-Profile: Gururaja Perumal Pazhani

Zitieren

APA

Kumar, S. P., Uthra, K. T., Chitra, V., Damodharan, N., & Pazhani, G. P. (2024). Challenges and mitigation strategies associated with Burkholderia cepacia complex contamination in pharmaceutical manufacturing. Archives of Microbiology, 206(4). https://doi.org/10.1007/s00203-024-03921-9

Vancouver

Kumar SP, Uthra KT, Chitra V, Damodharan N, Pazhani GP. Challenges and mitigation strategies associated with Burkholderia cepacia complex contamination in pharmaceutical manufacturing. Archives of Microbiology. 2024;206(4). doi:10.1007/s00203-024-03921-9

BibTeX
@article{Kumar2024,
  author = {Kumar, Sethuraman Prem and Uthra, Karupanagounder Thangaraj and Chitra, Vellapandian and Damodharan, Narayanasamy and Pazhani, Gururaja Perumal},
  title = {Challenges and mitigation strategies associated with Burkholderia cepacia complex contamination in pharmaceutical manufacturing},
  journal = {Archives of Microbiology},
  year = {2024},
  volume = {206},
  number = {4},
  doi = {10.1007/s00203-024-03921-9}
}
Kostenlos starten →